Drug Target Review – Issue #2 2017

Posted: 2 June 2017 | | No comments yet

Included in this issue: Technology convergence improves testing; Screening; Stem Cells; Targets; Mass Spectrometry; and Therapeutics in Alzheimer’s disease…

digtial issue #2 2017 feature image
  • Foreword: Technology convergence improves testing models
    Anton Simeonov, Scientific Director of the Division of Pre-Clinical Innovation (DPR) at the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
  • In-Depth Focus: Screening
  • Genomics: Review: biomarkers towards personalised therapy in cancer
    Mahvash Tavassoli and Katheryn Begg, King’s College London
  • In-Depth Focus: Stem Cells
  • Mass Spectrometry: Using native mass spectrometry to inform drug discovery
    Idlir Liko, OMass Technologies and University of Oxford; Timothy M Allison, OMass Technologies and University of Oxford; Hsin-Yung Yen, OMass Technologies and University of Oxford; Jonathan S.T. Hopper, OMass Technologies; Carol V. Robinson, OMass Technologies and University of Oxford
  • In-Depth Focus: Targets
  • Research area: CNS: Insights from discovery through clinical efficacy to support a new class of therapeutics in Alzheimer’s disease
    Petr Kocis, John A Hey, Susan Abushakra, Aidan Power, and Martin Tolar, Alzheon

The digital version of Issue #2 2017 is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here